• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同种异体间充质干细胞治疗可诱导马匹产生特异性同种抗体。

Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.

作者信息

Owens Sean D, Kol Amir, Walker Naomi J, Borjesson Dori L

机构信息

Department of Pathology, Microbiology, Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

出版信息

Stem Cells Int. 2016;2016:5830103. doi: 10.1155/2016/5830103. Epub 2016 Aug 28.

DOI:10.1155/2016/5830103
PMID:27648075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5018342/
Abstract

Background. It is unknown whether horses that receive allogeneic mesenchymal stem cells (MSCs) injections develop specific humoral immune response. Our goal was to develop and validate a flow cytometric MSC crossmatch procedure and to determine if horses that received allogeneic MSCs in a clinical setting developed measurable antibodies following MSC administration. Methods. Serum was collected from a total of 19 horses enrolled in 3 different research projects. Horses in the 3 studies all received unmatched allogeneic MSCs. Bone marrow (BM) or adipose tissue derived MSCs (ad-MSCs) were administered via intravenous, intra-arterial, intratendon, or intraocular routes. Anti-MSCs and anti-bovine serum albumin antibodies were detected via flow cytometry and ELISA, respectively. Results. Overall, anti-MSC antibodies were detected in 37% of the horses. The majority of horses (89%) were positive for anti-bovine serum albumin (BSA) antibodies prior to and after MSC injection. Finally, there was no correlation between the amount of anti-BSA antibody and the development of anti-MSC antibodies. Conclusion. Anti allo-MSC antibody development was common; however, the significance of these antibodies is unknown. There was no correlation between either the presence or absence of antibodies and the percent antibody binding to MSCs and any adverse reaction to a MSC injection.

摘要

背景。接受同种异体间充质干细胞(MSC)注射的马匹是否会产生特异性体液免疫反应尚不清楚。我们的目标是开发并验证一种流式细胞术MSC交叉配型程序,并确定在临床环境中接受同种异体MSC的马匹在注射MSC后是否会产生可检测到的抗体。方法。从参与3个不同研究项目的总共19匹马中采集血清。这3项研究中的马匹均接受了不匹配的同种异体MSC。通过静脉内、动脉内、肌腱内或眼内途径给予骨髓(BM)或脂肪组织来源的MSC(ad-MSC)。分别通过流式细胞术和ELISA检测抗MSC抗体和抗牛血清白蛋白抗体。结果。总体而言,37%的马匹检测到抗MSC抗体。大多数马匹(89%)在注射MSC之前和之后抗牛血清白蛋白(BSA)抗体均呈阳性。最后,抗BSA抗体的量与抗MSC抗体的产生之间没有相关性。结论。抗同种异体MSC抗体的产生很常见;然而,这些抗体的意义尚不清楚。抗体的存在与否以及抗体与MSC结合的百分比和对MSC注射的任何不良反应之间均无相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/be5c9e6b6d39/SCI2016-5830103.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/8e6280fa0e4c/SCI2016-5830103.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/8da4037014e7/SCI2016-5830103.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/be5c9e6b6d39/SCI2016-5830103.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/8e6280fa0e4c/SCI2016-5830103.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/8da4037014e7/SCI2016-5830103.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6818/5018342/be5c9e6b6d39/SCI2016-5830103.003.jpg

相似文献

1
Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.同种异体间充质干细胞治疗可诱导马匹产生特异性同种抗体。
Stem Cells Int. 2016;2016:5830103. doi: 10.1155/2016/5830103. Epub 2016 Aug 28.
2
Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses.反复关节内注射马同种异体外周血源性间充质干细胞不会引起马匹的细胞和体液免疫反应。
Vet Immunol Immunopathol. 2021 Sep;239:110306. doi: 10.1016/j.vetimm.2021.110306. Epub 2021 Aug 2.
3
Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.多次静脉注射同种异体马间充质干细胞不会引发全身性炎症反应,但会改变健康马匹的淋巴细胞亚群。
Stem Cell Res Ther. 2015 Apr 15;6(1):73. doi: 10.1186/s13287-015-0050-0.
4
Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.关节内注射同种异体滑膜间充质干细胞联合和不联合 LPS 给药后细胞毒性抗体的产生。
Front Immunol. 2022 Apr 27;13:871216. doi: 10.3389/fimmu.2022.871216. eCollection 2022.
5
Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.马异体骨髓来源的间充质基质细胞在体内引发抗体反应。
Stem Cell Res Ther. 2015 Apr 12;6(1):54. doi: 10.1186/s13287-015-0053-x.
6
Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies.同种异体主要组织相容性复合体不匹配的马骨髓间充质干细胞会被细胞毒性抗主要组织相容性复合体抗体靶向致死。
Equine Vet J. 2017 Jul;49(4):539-544. doi: 10.1111/evj.12647. Epub 2016 Dec 13.
7
Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.对患有肌腱损伤的马匹进行单次和重复同种异体肌腱源性间充质干细胞治疗的细胞和体液免疫原性研究。
Front Vet Sci. 2022 Feb 24;8:789293. doi: 10.3389/fvets.2021.789293. eCollection 2021.
8
Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.在马骨关节炎模型中关节内注射间充质干细胞(MSCs)后产生同种抗体:重复给药、MSC 炎症刺激和马白细胞抗原(ELA)相容性的影响。
Stem Cell Res Ther. 2020 Feb 7;11(1):52. doi: 10.1186/s13287-020-1571-8.
9
Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.马关节腔内注射自体、异体和异种间充质干细胞后的免疫反应研究。
Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.
10
Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.马实验模型中对间充质干细胞给药的炎症反应:自体、单次和重复剂量的同种异体混合细胞在健康关节中的作用。
BMC Vet Res. 2016 Mar 31;12:65. doi: 10.1186/s12917-016-0692-x.

引用本文的文献

1
Safety study of leucoreduced allogeneic pooled freeze-dried platelet-rich plasma in healthy equine joints.健康马关节中白细胞滤除的同种异体混合冻干富血小板血浆的安全性研究。
Front Vet Sci. 2025 Jul 14;12:1625431. doi: 10.3389/fvets.2025.1625431. eCollection 2025.
2
Comparing the Benefits and Drawbacks of Stem Cell Therapy Based on the Cell Origin or Manipulation Process: Addressing Immunogenicity.基于细胞来源或操作过程比较干细胞疗法的利弊:应对免疫原性
Immune Netw. 2023 Nov 23;23(6):e44. doi: 10.4110/in.2023.23.e44. eCollection 2023 Dec.
3
Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors.

本文引用的文献

1
Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.无血清培养基中培养的犬和马间充质干细胞具有改变的免疫表型。
Stem Cell Rev Rep. 2016 Apr;12(2):245-56. doi: 10.1007/s12015-015-9638-0.
2
Stem Cell Therapies in Clinical Trials: Progress and Challenges.临床试验中的干细胞疗法:进展与挑战。
Cell Stem Cell. 2015 Jul 2;17(1):11-22. doi: 10.1016/j.stem.2015.06.007.
3
Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.马异体骨髓来源的间充质基质细胞在体内引发抗体反应。
使用携带六个犬重编程因子的 Sendai 病毒载体在无饲养层条件下生成犬诱导多能干细胞。
Stem Cell Reports. 2024 Jan 9;19(1):141-157. doi: 10.1016/j.stemcr.2023.11.010. Epub 2023 Dec 21.
4
Umbilical cord mesenchymal stromal cells in serum-free defined medium display an improved safety profile.无血清定义培养基中的脐带间质基质细胞显示出改善的安全性特征。
Stem Cell Res Ther. 2023 Dec 12;14(1):360. doi: 10.1186/s13287-023-03604-0.
5
Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses.同种异体间充质基质细胞治疗自然发生的肌腱疾病:马的随机、对照、三盲先导研究。
Cells. 2023 Oct 24;12(21):2513. doi: 10.3390/cells12212513.
6
"Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial".脂肪源性间充质干细胞治疗女性性功能障碍:文献综述与一项临床试验的研究设计
Front Cell Dev Biol. 2022 Sep 28;10:956274. doi: 10.3389/fcell.2022.956274. eCollection 2022.
7
A Review of Fetal Bovine Serum in the Culture of Mesenchymal Stromal Cells and Potential Alternatives for Veterinary Medicine.胎牛血清在间充质基质细胞培养中的应用综述及兽医学的潜在替代物
Front Vet Sci. 2022 May 3;9:859025. doi: 10.3389/fvets.2022.859025. eCollection 2022.
8
Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.关节内注射同种异体滑膜间充质干细胞联合和不联合 LPS 给药后细胞毒性抗体的产生。
Front Immunol. 2022 Apr 27;13:871216. doi: 10.3389/fimmu.2022.871216. eCollection 2022.
9
Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.对患有肌腱损伤的马匹进行单次和重复同种异体肌腱源性间充质干细胞治疗的细胞和体液免疫原性研究。
Front Vet Sci. 2022 Feb 24;8:789293. doi: 10.3389/fvets.2021.789293. eCollection 2021.
10
Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis.基于间充质干细胞的疗法作为治疗系统性硬化症的新方法
Clin Rev Allergy Immunol. 2023 Jun;64(3):284-320. doi: 10.1007/s12016-021-08892-z. Epub 2022 Jan 15.
Stem Cell Res Ther. 2015 Apr 12;6(1):54. doi: 10.1186/s13287-015-0053-x.
4
Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.多次静脉注射同种异体马间充质干细胞不会引发全身性炎症反应,但会改变健康马匹的淋巴细胞亚群。
Stem Cell Res Ther. 2015 Apr 15;6(1):73. doi: 10.1186/s13287-015-0050-0.
5
Mesenchymal stem cells: immune evasive, not immune privileged.间充质干细胞:具有免疫逃逸能力,而非免疫特惠。
Nat Biotechnol. 2014 Mar;32(3):252-60. doi: 10.1038/nbt.2816. Epub 2014 Feb 23.
6
Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo.恒河猴间充质干细胞的同种异体反应性与剂量和单倍型有关,并限制了其在体内的持久细胞植入。
PLoS One. 2014 Jan 29;9(1):e87238. doi: 10.1371/journal.pone.0087238. eCollection 2014.
7
Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.经皮腔内注射和区域性灌注后,锝-99 标记的骨髓间充质干细胞在实验性诱导的腱病损中的分布和持续存在。
Equine Vet J. 2013 Nov;45(6):726-31. doi: 10.1111/evj.12063. Epub 2013 Apr 9.
8
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.间充质基质细胞(SafeCell)细胞疗法的安全性:临床试验的系统评价和荟萃分析。
PLoS One. 2012;7(10):e47559. doi: 10.1371/journal.pone.0047559. Epub 2012 Oct 25.
9
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.经心内膜注射异体与自体骨髓间充质干细胞治疗缺血性心肌病的比较:POSEIDON 随机试验。
JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321.
10
Equine IgE responses to non-viral vaccine components.马属动物对非病毒疫苗成分的 IgE 反应。
Vaccine. 2012 Dec 14;30(52):7615-20. doi: 10.1016/j.vaccine.2012.10.029. Epub 2012 Oct 23.